Navigate today’s most pressing health industry challenges with a leading global expert by your side.
ACO utilization & cost evaluation
Healthcare cost modeling
Preventive digital health
Insurance risk assessment
Medicare plan selection solution
Healthcare risk adjustment
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Property & casualty advisory services
Modern flood insurance program
Investment, advisory & trading services
Financial modeling & industrialization
Geographic rating insights
Premium comparison platform
Retirement & Benefits
Deliver on the promises of the past and create smart solutions for the future.
Pension administration & communication
Retirement benefits administration platform
Compensations & benefits
Benefit plan evaluation
Health & welfare benefits administration platform
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
Auto policy underwriting
Software performance enhancement
Mortgage platform for investments & reinsurance
Solvency II reporting & compliance
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Jessica Naber is a principal and consulting actuary in the Health Practice of the Indianapolis office of Milliman. She is a project lead in the pharmaceutical consulting group. She joined the firm in 2011.
Jessica has been consulting with pharmaceutical companies since 2015. Her two primary focuses are, (1) consulting related to gene and cell therapies and the rare diseases they treat, and (2) leading technical projects that involve claims databases, data analytics, research, and model building.
Jessica has also been involved in the creation and development of Milliman DNA (Demand Insight Accelerator), a product that provides synthesized clinical and scientific research for approved and pipeline gene and cell therapies and estimates the costs and cases associated with these therapies. The product’s intended users are primary insurers, secondary insurers, and pharmaceutical manufacturers.
Jessica has been the lead on many types of technical and non-technical projects, including:
Prior to consulting with pharmaceutical manufacturers, Jessica was involved with supporting Accountable Care Organizations (ACOs) and provider payment reform, including:
Jessica has led and participated in a variety of research efforts. She has authored white papers and reports, some of which were published by the Society of Actuaries or their affiliated magazine. She has also presented at multiple SOA conferences and has been a guest on the SOA’s Research Insights podcast.